no changes were observed in spleen cells/mg , splenocyte viability , or in t and b cell proliferation mediated by concanavalin a ( con-a ) and lipopolysaccharide ( lps ) , respectively , with either cdf or 4ct treatment .
C0007634
cells
C1155008
b